COVID-19 has changed our way of life. Everyone is looking for information about how to stay safe and healthy, but those affected by lung cancer have a sense of urgency others can only imagine. A livestream series is giving them an opportunity to connect face-to-face, meet experts, and talk about their unique questions and challenges. View short clips and register for the April 23 live talk at LCRF.org/together.
LCRF has developed a new resource addressing common questions those affected by lung cancer have about the current pandemic. Download it directly at LCRF.org/covid19-download. Other free lung cancer materials are available at LCRF.org/resources.
Let's hear it for... Our #TogetherSeparately live talk and roundtable moderators, who have taken time out of their busy schedules to share their knowledge: Dr. Chad Pecot; Dr. Mark Kris; Ali Schaffer, LCSW; Sarah Cassidy; and Dr. David Spigel.
The #TogetherSeparately livestream has given hundreds of people who care about lung cancer a place to discuss their concerns. You're invited to keep the conversation going by joining the Lung Cancer Community group on Facebook. Join us and introduce yourself!
The FDA approved immunotherapy drug durvalumab (Imfinzi) in combination with chemotherapy for the first-line treatment of extensive stage small cell lung cancer (SCLC). This is now the 4th immunotherapy drug approved to treat SCLC, which expands the options for treatment of this aggressive type of lung cancer. The rapid pace of FDA approvals in recent years is a testament to the importance of research.
In the past, those who wanted to participate in Free to Breathe Yoga needed to come to Madison or Baltimore. This year, you can join from anywhere! A pandemic won't get in the way of a passionate community that wants to make a difference. All levels are welcome, even if you've never done yoga before.